$BMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.
Page: < prev 1 ... 27 28 29 30 31 32 33 34 34 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 14.00 | 313 | 4,382 | 92,033 | |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 11.74 | 521 | 6,117 | 92,346 | |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.13 | 177 | 1,085 | 92,867 | |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.37 | 521 | 3,319 | 93,044 | |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.46 | 153 | 3,895 | 0 | 153 to 0 (-100.00 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.39 | 153 | 3,885 | 153 | 306 to 153 (-50.00 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.37 | 153 | 3,882 | 306 | 459 to 306 (-33.33 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.36 | 154 | 3,905 | 459 | 613 to 459 (-25.12 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.33 | 153 | 3,875 | 613 | 766 to 613 (-19.97 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.31 | 306 | 7,745 | 766 | 1.1 K to 766 (-28.54 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.30 | 153 | 3,871 | 1,072 | 1.2 K to 1.1 K (-12.49 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.19 | 153 | 3,854 | 1,225 | 1.4 K to 1.2 K (-11.10 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 25.00 | 154 | 3,850 | 1,378 | 1.5 K to 1.4 K (-10.05 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 14.00 | 313 | 4,382 | 1,532 | 1.2 K to 1.5 K (+25.68 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 11.74 | 521 | 6,117 | 1,291 | 770 to 1.3 K (+67.66 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.13 | 177 | 1,085 | 698 | 521 to 698 (+33.97 %) |
Oct 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.37 | 521 | 3,319 | 521 | 0 to 521 |
Oct 15 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | M | 8.05 | 5,000 | 40,250 | 226,000 | |
Oct 15 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Sell | S | 27.34 | 5,000 | 136,700 | 2,607 | 7.6 K to 2.6 K (-65.73 %) |
Oct 15 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Buy | M | 8.05 | 5,000 | 40,250 | 7,607 | 2.6 K to 7.6 K (+191.79 %) |
Oct 25 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 17.54 | 833 | 14,611 | 91,200 | |
Oct 25 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 26.00 | 833 | 21,658 | 0 | 833 to 0 (-100.00 %) |
Oct 25 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 17.54 | 833 | 14,611 | 833 | 0 to 833 |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 12,380 | 100,278 | 219,584 | |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 26.00 | 12,380 | 321,880 | 0 | 12.4 K to 0 (-100.00 %) |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 12,380 | 100,278 | 12,380 | 0 to 12.4 K |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 17.54 | 8,333 | 146,161 | 93,565 | |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 26.00 | 8,333 | 216,658 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 17.54 | 8,333 | 146,161 | 8,333 | 0 to 8.3 K |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 6.13 | 10,000 | 61,300 | 430,233 | |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 2,500 | 10,000 | 440,233 | |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.30 | 1,250 | 31,625 | 10,000 | 11.3 K to 10 K (-11.11 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.22 | 1,250 | 31,525 | 11,250 | 12.5 K to 11.3 K (-10.00 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.14 | 1,250 | 31,425 | 12,500 | 13.8 K to 12.5 K (-9.09 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.13 | 1,250 | 31,413 | 13,750 | 15 K to 13.8 K (-8.33 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.11 | 1,250 | 31,388 | 15,000 | 16.3 K to 15 K (-7.69 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.10 | 1,756 | 44,076 | 16,250 | 18 K to 16.3 K (-9.75 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.08 | 1,250 | 31,344 | 18,006 | 19.3 K to 18 K (-6.49 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.00 | 100 | 2,500 | 19,256 | 19.4 K to 19.3 K (-0.52 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 25.00 | 644 | 16,100 | 19,356 | 20 K to 19.4 K (-3.22 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 24.99 | 1,250 | 31,238 | 20,000 | 21.3 K to 20 K (-5.88 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 24.91 | 48 | 1,196 | 21,250 | 21.3 K to 21.3 K (-0.23 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 24.90 | 1,202 | 29,930 | 21,298 | 22.5 K to 21.3 K (-5.34 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 6.13 | 10,000 | 61,300 | 22,500 | 12.5 K to 22.5 K (+80.00 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 2,500 | 10,000 | 12,500 | 10 K to 12.5 K (+25.00 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | M | 6.13 | 5,000 | 30,650 | 231,000 | |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Sell | S | 25.10 | 5,000 | 125,500 | 2,607 | 7.6 K to 2.6 K (-65.73 %) |
Oct 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Buy | M | 6.13 | 5,000 | 30,650 | 7,607 | 2.6 K to 7.6 K (+191.79 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | M | 7.16 | 5,000 | 35,800 | 315,000 | |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.28 | 500 | 12,640 | 4,895 | 5.4 K to 4.9 K (-9.27 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.20 | 500 | 12,600 | 5,395 | 5.9 K to 5.4 K (-8.48 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.15 | 500 | 12,575 | 5,895 | 6.4 K to 5.9 K (-7.82 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.14 | 500 | 12,570 | 6,395 | 6.9 K to 6.4 K (-7.25 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.10 | 500 | 12,550 | 6,895 | 7.4 K to 6.9 K (-6.76 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.07 | 500 | 12,535 | 7,395 | 7.9 K to 7.4 K (-6.33 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.06 | 100 | 2,506 | 7,895 | 8 K to 7.9 K (-1.25 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.05 | 500 | 12,525 | 7,995 | 8.5 K to 8 K (-5.89 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.05 | 400 | 10,020 | 8,495 | 8.9 K to 8.5 K (-4.50 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 25.00 | 500 | 12,500 | 8,895 | 9.4 K to 8.9 K (-5.32 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 24.90 | 500 | 12,450 | 9,395 | 9.9 K to 9.4 K (-5.05 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | M | 7.16 | 5,000 | 35,800 | 9,895 | 4.9 K to 9.9 K (+102.15 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 793 | 5,123 | 1,194,114 | |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 19,207 | 124,077 | 1,194,907 | |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 25.10 | 793 | 19,904 | 6,695 | 7.5 K to 6.7 K (-10.59 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 25.00 | 19,207 | 480,175 | 7,488 | 26.7 K to 7.5 K (-71.95 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 793 | 5,123 | 26,695 | 25.9 K to 26.7 K (+3.06 %) |
Oct 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 19,207 | 124,077 | 25,902 | 6.7 K to 25.9 K (+286.89 %) |
Sep 27 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 12,500 | 101,250 | 231,964 | |
Sep 27 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 24.50 | 12,500 | 306,250 | 0 | 12.5 K to 0 (-100.00 %) |
Sep 27 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 12,500 | 101,250 | 12,500 | 0 to 12.5 K |
Sep 26 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 10,000 | 64,600 | 1,214,114 | |
Sep 26 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 24.00 | 10,000 | 240,000 | 6,695 | 16.7 K to 6.7 K (-59.90 %) |
Sep 26 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 10,000 | 64,600 | 16,695 | 6.7 K to 16.7 K (+149.37 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 14.00 | 4,687 | 65,618 | 101,898 | |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 11.74 | 521 | 6,117 | 106,585 | |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.13 | 177 | 1,085 | 107,106 | |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.37 | 521 | 3,319 | 107,283 | |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.46 | 590 | 13,841 | 0 | 590 to 0 (-100.00 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.34 | 1,082 | 25,254 | 590 | 1.7 K to 590 (-64.71 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.33 | 100 | 2,333 | 1,672 | 1.8 K to 1.7 K (-5.64 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.30 | 690 | 16,077 | 1,772 | 2.5 K to 1.8 K (-28.03 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.28 | 981 | 22,838 | 2,462 | 3.4 K to 2.5 K (-28.49 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.27 | 100 | 2,327 | 3,443 | 3.5 K to 3.4 K (-2.82 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.20 | 300 | 6,960 | 3,543 | 3.8 K to 3.5 K (-7.81 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.19 | 291 | 6,748 | 3,843 | 4.1 K to 3.8 K (-7.04 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.18 | 591 | 13,699 | 4,134 | 4.7 K to 4.1 K (-12.51 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.11 | 590 | 13,635 | 4,725 | 5.3 K to 4.7 K (-11.10 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 23.00 | 591 | 13,593 | 5,315 | 5.9 K to 5.3 K (-10.01 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 14.00 | 4,687 | 65,618 | 5,906 | 1.2 K to 5.9 K (+384.50 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 11.74 | 521 | 6,117 | 1,219 | 698 to 1.2 K (+74.64 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.13 | 177 | 1,085 | 698 | 521 to 698 (+33.97 %) |
Sep 24 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.37 | 521 | 3,319 | 521 | 0 to 521 |
Sep 20 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 10,000 | 64,600 | 1,224,114 | |
Sep 20 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 23.00 | 10,000 | 230,000 | 6,695 | 16.7 K to 6.7 K (-59.90 %) |
Sep 20 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 10,000 | 64,600 | 16,695 | 6.7 K to 16.7 K (+149.37 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.72 | 100 | 2,272 | 33,124 | 33.2 K to 33.1 K (-0.30 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.71 | 591 | 13,422 | 33,224 | 33.8 K to 33.2 K (-1.75 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.70 | 500 | 11,350 | 33,815 | 34.3 K to 33.8 K (-1.46 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.69 | 800 | 18,152 | 34,315 | 35.1 K to 34.3 K (-2.28 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.68 | 200 | 4,536 | 35,115 | 35.3 K to 35.1 K (-0.57 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.67 | 700 | 15,869 | 35,315 | 36 K to 35.3 K (-1.94 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.66 | 1,200 | 27,192 | 36,015 | 37.2 K to 36 K (-3.22 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.65 | 3,251 | 73,635 | 37,215 | 40.5 K to 37.2 K (-8.03 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.64 | 2,349 | 53,181 | 40,466 | 42.8 K to 40.5 K (-5.49 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.63 | 3,890 | 88,031 | 42,815 | 46.7 K to 42.8 K (-8.33 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.62 | 3,619 | 81,862 | 46,705 | 50.3 K to 46.7 K (-7.19 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.61 | 5,507 | 124,513 | 50,324 | 55.8 K to 50.3 K (-9.86 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 6.13 | 6,751 | 41,384 | 258,000 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 5.15 | 4,291 | 22,099 | 264,751 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 7.76 | 8,958 | 69,514 | 269,043 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.50 | 100 | 2,050 | 0 | 100 to 0 (-100.00 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.47 | 100 | 2,047 | 100 | 200 to 100 (-50.00 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.46 | 2,000 | 40,920 | 200 | 2.2 K to 200 (-90.91 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.37 | 900 | 18,333 | 2,200 | 3.1 K to 2.2 K (-29.03 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.36 | 500 | 10,180 | 3,100 | 3.6 K to 3.1 K (-13.89 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.35 | 1,000 | 20,350 | 3,600 | 4.6 K to 3.6 K (-21.74 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.29 | 616 | 12,499 | 4,600 | 5.2 K to 4.6 K (-11.81 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.28 | 4,800 | 97,344 | 5,216 | 10 K to 5.2 K (-47.92 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.27 | 4,854 | 98,391 | 10,016 | 14.9 K to 10 K (-32.64 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.26 | 2,286 | 46,314 | 14,870 | 17.2 K to 14.9 K (-13.32 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.25 | 200 | 4,050 | 17,156 | 17.4 K to 17.2 K (-1.15 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.23 | 100 | 2,023 | 17,356 | 17.5 K to 17.4 K (-0.57 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.18 | 100 | 2,018 | 17,456 | 17.6 K to 17.5 K (-0.57 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.15 | 100 | 2,015 | 17,556 | 17.7 K to 17.6 K (-0.57 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.14 | 200 | 4,028 | 17,656 | 17.9 K to 17.7 K (-1.12 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.13 | 644 | 12,964 | 17,856 | 18.5 K to 17.9 K (-3.48 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.12 | 1,500 | 30,180 | 18,500 | 20 K to 18.5 K (-7.50 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 6.13 | 6,751 | 41,384 | 20,000 | 13.2 K to 20 K (+50.95 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 5.15 | 4,291 | 22,099 | 13,249 | 9 K to 13.2 K (+47.90 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 7.76 | 8,958 | 69,514 | 8,958 | 0 to 9 K |
Sep 07 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 13,536 | 109,642 | 244,464 | |
Sep 07 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 22.50 | 13,536 | 304,560 | 0 | 13.5 K to 0 (-100.00 %) |
Sep 07 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 13,536 | 109,642 | 13,536 | 0 to 13.5 K |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Option Exercise | M | 6.13 | 90,000 | 551,700 | 628,243 | |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.60 | 5,693 | 128,662 | 55,831 | 61.5 K to 55.8 K (-9.25 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.59 | 900 | 20,331 | 61,524 | 62.4 K to 61.5 K (-1.44 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.58 | 4,000 | 90,320 | 62,424 | 66.4 K to 62.4 K (-6.02 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.57 | 2,700 | 60,939 | 66,424 | 69.1 K to 66.4 K (-3.91 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.56 | 1,000 | 22,560 | 69,124 | 70.1 K to 69.1 K (-1.43 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.55 | 3,700 | 83,435 | 70,124 | 73.8 K to 70.1 K (-5.01 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.54 | 3,500 | 78,890 | 73,824 | 77.3 K to 73.8 K (-4.53 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.53 | 900 | 20,277 | 77,324 | 78.2 K to 77.3 K (-1.15 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.52 | 500 | 11,260 | 78,224 | 78.7 K to 78.2 K (-0.64 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.51 | 200 | 4,502 | 78,724 | 78.9 K to 78.7 K (-0.25 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.50 | 5,000 | 112,500 | 78,924 | 83.9 K to 78.9 K (-5.96 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.49 | 1,500 | 33,735 | 83,924 | 85.4 K to 83.9 K (-1.76 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.48 | 4,597 | 103,341 | 85,424 | 90 K to 85.4 K (-5.11 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.47 | 3,501 | 78,667 | 90,021 | 93.5 K to 90 K (-3.74 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.46 | 3,600 | 80,856 | 93,522 | 97.1 K to 93.5 K (-3.71 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.46 | 100 | 2,246 | 97,122 | 97.2 K to 97.1 K (-0.10 %) |